Janssen, “We’ll carry out extensive & global Phase II clinical trial of Hanmi Pharm’s obesity and diabetes biologic”

Published: 2018-07-20 16:26:00
Updated: 2018-07-20 17:37:02

Hanmi Pharm’s new obesity & diabetes biologic being developed by Janssen  HM12525A(Janssen Code Name: JNJ-64565111) will additionally take an extensive global Phase II clinical trial.

This Phase II clinical trial will evaluate safety and efficacy on 188 extreme obesity patients with diabetes. Ja...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.